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The human platelet-activating factor (PAF) receptor gene exists as a single copy on chromosome 1. We identified two 5’-noncoding exons, each 
of which has distinct transcriptional initiation sites. These exons are alternatively spliced to a common splice acceptor site on a third exon that 
contains the total open reading frame to yield two different species of functional mRNA (Transcript 1 and 2). Transcript 1 has consensus equences 
for transcription factor NF-KB and Sp-1, and the Initiator (mr) sequence. homologous to the murine terminal deoxynucleotidyltransferase gene. 
Transcript 2 also contains consensus equences for transcription factor AP-1, AP-2, and Sp-1. Transcripts 1 and 2 were both detected in heart, 
lung, spleen, and kidney, whereas only Transcript 1 was found in peripheral eukocytes, adifferentiated human eosinophilic ell line (EoL-1 cells), 
and brain. Existence of distinct promoters was thus suggested to play a role in the regulatory control of PAF receptor gene expression in different 
human tissues and cells. 
Lipid mediator; Alternative splicing; Primer extension; Initiator (1nr); Human leukocyte 
1. INTRODUCTION 
Platelet-activating factor (PAF, 1-0-alkyl-2-acetyl- 
sn-glycero-3-phosphocholine) is a lipid mediator that 
possesses diverse and potent biological effects on a vari- 
ety of cells and tissues [l-4]. PAF has a role in activa- 
tion of neutrophils and platelets, microvascular leakage, 
smooth muscle contraction, and activation of early on- 
cogenes. Specific PAF receptors on the plasma mem- 
brane of these target cells mediate these versatile proc- 
esses. 
Recently, we isolated cDNAs for a PAF receptor 
from guinea pig lung and human leukocytes [5,6]. 
Northern blot analysis showed that the PAF receptor 
mRNA was extremely abundant in human peripheral 
leukocytes, a human eosinophilic cell line (EoL-1 cells) 
differentiated with GM-CSF, IL-5, and n-butyrate, and 
a human promyelocytic leukemia cell line (HL-60 cells) 
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differentiated with dibutyryl CAMP or la,25(0H),vita- 
min D, [68]. The transcript was also detected in the 
spleen, lung, kidney, and placenta, but scarcely present 
in undifferentiated EoL-1 cells and undifferentiated 
HL-60 cells, as determined by Northern blot analysis 
[S-7,9,10]. 
Human PAF receptor cDNAs have also been cloned 
from human heart and cell lines (U937 myeloid cell line 
and diffentiated HL-60 cells) [7,11,12]. All these human 
cDNAs contained an identical coding region sequence. 
Isolation of a cDNA from a human heart cDNA library 
[l l] revealed a different sequence beyond 39 base pairs 
upstream of the ATG initiation codon (-186 to -39). 
It suggested to us the possibility that human PAF recep- 
tor cDNA may have at least two different S-termini. 
We report here cloning of the human PAF receptor 
gene, which possesses two alternatively spliced 5’-non- 
coding exons that might be under control of two distinct 
promoter sequences. 
2. MATERIALS AND METHODS 
2.1. Screening of a genomic library 
A human placental genomic library constructed in a 1 phage vector 
EMBL3/SP6/T7 (Clontech) was screened with the human PAF recep- 
tor cDNAs isolated from human peripheral eukocytes [6] and from 
the human heart [l l] as a probe, under high-stringency hybridization 
conditions. Various restriction fragments from positive clones were 
subcloned into the plasmid vector pBluescript SK(-) (Stratagene) for 
further analysis and sequencing by dideoxy nucleotide chain-tennina- 
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tion method [13] using Sequenase Ver. 2.0 (United States Biochemi- 
cal). 
2.2. Southern blot analysis of genomic DNA 
Human placental DNA digested with XhoI, HindHI, BgnI, and 
EcoRI were electrophoresed in a 0.7% agarose gel, and blotted onto 
a nylon membrane (Hybond-N, Amersham) [14]. The membrane was 
hybridized with a ‘*P-labeled BgCIIIHindIII fragment of human PAF 
receptor cDNA (nucleotides 161-1,219) [6]. Hybridization conditions 
were as follows: 6 x SSC, 5 x Denhardt’s solution (0.1% BSA, 0.1% 
polyvinylpyrrolidone and 0.1% Ficoll400), 0.5% SDS, 4OO@ml heat- 
denatured salmon sperm DNA, and the radiolabeled probe (> 5 x IO6 
cpm/ml) at 65°C for 20 h. The membrane was washed with 0.1 x SSCl 
0.5% SDS at 68°C for 30 min, and exposed to X-ray films at -70°C 
for three days, using intensifying screens. 
2.3. Preparation of poly(A)+ RNA 
EoL-1 cells were grown and differentiated as described [6]. RNAs 
were extracted from EoL-1 cells and human leukocytes by the acid- 
phenol method [15], and poly(A)’ RNA were purified using Oligotex- 
dT30 (Takara Shuzo, Kyoto, Japan). Poly(A)’ RNAs for human lung, 
spleen, and kidney were obtained from Clontech. Human heart 
poly(A)’ RNA was obtained as described [I I]. 
2.4. Primer extension analysis 
Primer extension analysis was performed with specific oligonucleo- 
tides for each form of the transcript: L2 (5’-CTGTAG- 
CAGGGGCAGCGGCTTC-3’, complementary to nucleotides -60 to 
-39 of human leukocyte PAF receptor cDNA [6]), H2 (5’- 
TGACTTCTCGGGGAGCTCAGG-3’, complementary to nucleo- 
tides -149 to -169 of human heart PAF receptor cDNA [I I]). Both 
primers were “P-labeled at their 5’-termini by T4 polynucleotide ki- 
nase (Takara Shuzo). Poly(A)’ RNA (3 pg) from the heart or differen- 
tiated EoL-1 cells was used as a template for analysis of transcription 
start site of each form of the transcript. Each “P-labeled primer 
(2 x IO5 cpm) was annealed to either 3 pg of heart or EoL-1 cell 
poly(A)’ RNA at 65°C for 3 h in a 30 ~1 solution of hybridization 
buffer (IO mM Tris-HCl, pH 8.3, 1 mM EDTA, 0.25 M KC]). The 
annealed RNA/primer mixture was extended with 5 units of Moloney 
murine leukemia virus (M-MuLV) reverse transcriptase (BRL) at 
37°C for 60 min. The product was ethanol-precipitated and redis- 
solved in 5 mM Tris-HCI pH 7.5 containing 48% formamide. After 
electrophoresis n6% polyacrylamide gel containing 8 M urea [14], the 
length of each transcript was compared with a DNA sequence ladder 
obtained using the same primer. 
2.5. Isolation of human PAF receptor 5’-cDNA ends 
Rapid amplification of cDNA ends (RACE) was carried out essen- 
tially as described [16]. First strand cDNA was synthesized from 
EoL-1 cell poly(A)’ RNA using a specific primer (C3: 5’-TGATGAA- 
GAAAAGGCAGCCAGC-3’), which is complementary to nucleo- 
tides +277 to +298. Excess primer was removed using a Centricon- 
spin filter (Amicon), and the single-stranded cDNA was polyadenyl- 
ated at its 3’-terminus using terminal deoxynucleotidyltransferase in 
excess presence of dATP. First-stage polymerase chain reaction (PCR) 
was then performed on a small aliquot of the polyadenylated first 
strand cDNA, with three primers: C2 (5’-CCATGGT- 
GAGGTTCACC-3’, complementary to nucleotides +I68 to +184); 
adaptor (GACTCGAGTCGACATCG); and adaptor-(dT using 
AmpliTaq DNA polymerase (Perkin-Elmer Cetus). Finally, second- 
stage PCR was performed using 1~1 of the first-stage PCR products 
as template with the adaptor and L2 as primers. RACE products were 
separated by electrophoresis, and specific products, determined by 
Southern blot analysis, were gel-excised, cloned in a pBluescript SK(-) 
vector, and sequenced for analysis of the 5’-cDNA ends. 
2.6. Chromosome localization of the PAF receptor gene 
A panel of 25 human-hamster somatic hybrid DNAs (BIOS Corp., 
New Haven, CT) was analyzed by PCR to determine the chromosomal 
130 
localization of the human PAF receptor gene. PCR was carried out 
using specific pairs of primers for exon 1 (Ll and L2), exon 2 (HI and 
H3), and exon 3 (C3 and C4). H3 (5’~CTGAGAAACAG- 
CAGGGACAA-3’) is complementary to nucleotide -39 to -58 of 
exon 2. C4 (5’-GCATCATCTTTGTGCTCGGG-3’) is nucleotide 
+68 to +87 of exon 3. Amplified fragments were electrophoresed and 
visualized by ethidium bromide staining. Aliquots were analyzed by 
restriction enzyme digestion to verify authenticity of the amplified 
product. 
2.7. Detection of expressed PAF receptor mRNA by reverse transcrip- 
tase-polymerase chain reaction (RT-PCR) 
Poly(A)’ RNA (1 /fg) was transcribed with M-MuLV reverse tran- 
scriptase into cDNA, using random hexanucleotides (0.2pg) as prim- 
ers and the cDNA was then used for PCR. PCR primers used were 
Cl (5’~CCCGAGCACAAAGATGATGC-3’, complementary to nu- 
cleotide +87 to +68 of exon 3) [6], in combination of either Ll (5’- 
GGCTGGGGCCAGGACCCAGA-3’, nucleotide -104 to -85 of 
exon 1) [6] or HI (5’-CCTGAGCTCCCCGAGAAGTCA-3’, nucleo- 
tide - 165 to - 145 of exon 2) [ 1 I]. Amplified fragments were analyzed 
by agarose gel electrophoresis. Authentic bands were determined by 
selective nzyme digestion. 
3. RESULTS AND DISCUSSION 
3.1. Isolation of genomic clones for the PAF receptor 
Upon screening of approximately 1 x lo6 plaques of 
the human genomic library with the cDNA probe for 
the human leukocyte PAF receptor, we obtained three 
positive clones. Partial sequence analysis of these clones 
revealed that each contained the entire PAF receptor 
open reading frame and the entire 3’-untranslated re- 
gion reported by Nakamura et al. [6]. All three clones, 
however, contained only -1 to -38 of the 5’-untrans- 
lated region, which is common to both leukocyte and 
heart PAF receptor cDNAs [6,11]. They all lacked ei- 
ther the sequence from -39 to -112 of leukocyte or 
from -39 to -186 of heart cDNAs. A human genomic 
library was thus rescreened using DNA probes corre- 
sponding to these specific cDNA sequences: -39 to 
-104 (66 bases) of the leukocyte PAF receptor cDNA 
and -39 to -180 (142 bases) of the heart PAF receptor 
cDNA. The screening of about 1 x IO6 plaques yielded 
2 independent clones each for the specific probe. Se- 
quences around exon-intron junctions were determined 
by comparison of cDNA and genomic sequences. As 
shown in Fig. 1, we identified two distinct exons for the 
5’-flanking noncoding regions (exons 1 and 2). The cod- 
ing region is situated as an intronless exon designated 
as exon 3. The gene spreads out over more than 20 
kilobase pairs in length. Sequences around splice junc- 
tions are shown in Fig. 2. The intron/exon boundary 
sequences conform to the consensus GT/AG sequence 
117,181. 
3.2. Southern blot analysis 
For Southern blot analysis, the human placental 
DNA was digested with several restriction enzymes. As 
shown in Fig. 3, the digestion with XhoI, HindIII, BgflI, 
or EcoRI gave a single positive fragment of 17, 5.4, 6.0, 
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Fig. 1. Map of the human PAF receptor gene. (A) A schematic representation of the human PAF receptor mRNA. Small arrows indicate synthetic 
oligonucleotides for primer extension, RACE and PCR (see the text). (B) Genomic organization of the three exons of the human PAF receptor 
gene. Seven phages were isolated with the PAF receptor cDNA. Exons are indicated by closed boxes. Restriction sites for XhoI and Hind111 are 
indicated by vertical arrows. 
or 12 kilobase pairs (kb), respectively. The lengths of 
positive bands were in agreement with expected DNA 
fragments, as presented in the restriction map shown in 
Fig. 3. Southern blot analysis showed that the coding 
region of the PAF receptor gene exists as a single copy 
in a haploid genome. 
3.3. Chromosomal localization of PAF receptor gene 
There was no mutual overlap between genomic clones 
coding for three exons, hence large introns must sepa- 
rate exons 1,2, and 3. The chromosomal ocalization of 
three exons for the PAF receptor gene was determined, 
using a panel of somatic cell human-hamster hybrid 
DNA samples. PAF receptor genomic DNAs specific to 
exons 1,2, or 3 were amplified by PCR only in a normal 
human genomic DNA sample and hybrid clones 867, 
937, and 1099. Specific PCR products were undetecta- 
ble in the remaining 20 hybrid and hamster DNA sam- 
ples (data not shown). Thus, we could assign the PAF 
receptor gene (exons 1, 2, and 3) unequivocally to 
human chromosome 1 [19]. 
3.4. Determination of the transcription start sites of the 
human PAF receptor gene 
The transcription initiation site was determined by 
either primer extension and/or S-RACE. Two oligonu- 
cleotides, L2 and H2 were synthesized, based on se- 
quences from the 5’-termini of the published sequences 
for human leukocyte and heart PAF receptor cDNAs, 
respectively [6,11]. Since the EoL-1 PAF receptor 
cDNA shared a common sequence with the leukocyte 
cDNA at the S-terminus beyond -39 base pairs (bp) 
from initial ATG (Izumi, T., unpublished observation), 
poly(A)’ RNA from either EoL-1 cells or heart was 
used to determine the transcriptional start site for the 
leukocyte-type transcript (Transcript 1) or the heart- 
type transcript (Transcript 2), respectively. By primer 
extension analyses, a single start site was identified for 
Transcript 1, and two sites for Transcript 2. The major 
bands were observed at position -327 in EoL-1 cells 
(Fig. 4A) and at positions -259 and -249 in the heart 
(Fig. 4B). 
With the 5’-RACE method, three different products 
were identified using EoL-1 cell poly(A)’ RNA, sub- 
cloned and sequenced. The starting site for each product 
was assigned at position -400, -327, and -137, respec- 
tively. Thus, the initiation site at -327 was completely 
identical to that determined by primer extension. The 
other two starting positions (-400 and -137) by 5’- 
RACE were not detected by primer extension under our 
reaction conditions. Thus, a cytidine residue at position 
-327 was considered as the major transcription initia- 
tion site for the leukocyte-type transcript (Transcript 1). 
Sequence analysis of the region upstream of the tran- 
scription initiation site of Transcript 1 revealed that the 
putative promoter region of this gene has neither TATA 
nor CCAAT box, but does have consensus sequences 
for transcription factors NF-KB and Sp-1 . Interestingly, 
the nucleotide sequence surrounding the putative tran- 
scriptional start site of Transcript 1 (TCCTCTTTCT- 
CAC, -4 to +9 relative to the initiation site) was re- 
peated 73 bp upstream, where a 5’-RACE product was 
indeed found to start. Thus, this initiation sequence was 
identical in two (-400 and -327) of the three putative 
initiation sites of Transcript 1 suggested by S-RACE. 
This sequence is highly homologous to the Initiator 
(Znr) (CCTCATTCT), which was found in the murine 
terminal deoxynucleotidyltransferase gene (TdT) 
[20,21]. Though the murine TdT gene also lacks TATA 
box and CCAAT box, the sequence (Znr) is reported to 
represent the functional promoter related to cellular 
differentiation and to development [20,21]. It remains 
to be clarified, however, whether these consensus motifs 
are related to gene activation during cellular differentia- 
tion of HL-60 cells or EoL-1 cells [68]. 
The 5’-upstream region for the two initiation sites of 
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ATCTGTTCCCATGGGGTTTCTGGGCTCAATGTTTCTTGGTCTCCA riw&uu- 
GTCATGCCCCTGACCACAGTGGCTCTCTTCCGAGCTCCTCTCTTCTCCCTCCACTTTATATC 
TCTTTTGTCTTGGATCTTACCTTGTCTTTGTCCCTGAATCCTCT 
CCCGGTGTTTACATCTGTCTTTTTCCCCTGAGCCTC~TCCCTCCATCCATTCCT~ 
sp-1 
TCTCATTTTTTTTCCCGACTCCCTCCTGCCTCCTCCCTTTCTCCTT~ATTTTCCT~TC 
CCTCATCTCTCCTCCC& TCTCAT’XTCCCTTTTTTCGCTCTCTTGAGT 
ACATGCACTTGCTTTCTCTCTCTTGCTTT ~CTTAGCTCCTNCCACGG 
GCGCTGTCTACACCCCACCCCATCCCTCGCTCTTTGAGAA 
23 
9.4 
6.6 
4.4 
TCTGGCGGCCCAGCTTGGATTCCTGTGGTACCCCTTGA 
TTCCTCCCAGGGGTGACTTGTAGTGATACGCTCTGTTTCTTC~CTTCTGC~TTGCCAG 
ACAGCATAGAGGCTGAGGCTGGGGCCAGGACCCAGACCCAGACAGAGACACACGGTCACTGCAGCT 
2.3 
2.0 
GAAGCCGCTGCCCCTGCTACAGgEaaggggggattccgtgg 
-3g4 intron 
2 
TTTGTACACCCATTGTACTGGCCTCCTGTGGGCAAACTGGCTG 
TGTGTCCCCTCAGACAGGGTGCCTTCTGlUGCAGCTTTGGG 
GCTCACTGGATTTGGGGCTGTACCCATTGAATTGAAGCCCGGGCTCC~ 
--_ --..__~..~.~..-I_ 
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CGGTGACCTTGGTGTTGGGG CCWCAGGAGCTGGCTTCCTGGCCTCAGCTGCCCTG 
sp-1 . l 
cccACccAGCAGAGCCCGCA~C~CCTTTCCTAATCCTTCATCCTGCTGCTGcTcATT 
Fig. 3. Genomic Southern blot analysis of the human PAF receptor 
gene. Human placental DNA (1Opg) was digested with XhoI, HindHI, 
BgZII, or EcoRI, electrophoresed on a 0.7% agarose gel, and trans- 
ferred to a Hybond-N nylon membrane (Amersham). The filter was 
hybridized with the “P-labeled 1,059-base BglIIIHindIII fragment. 
The diagram at the bottom of the figure indicates the length of the 
bands hybridized with the 32P-labeled Bg[II/HindIII fragment used as 
CCAGGAAACATGCTCTCA~ACCCCCATCTGCCTCAGCCTC~TGTCACTGCCTGGAC a probe. 
CATTGTCCCTGCTGTTTCTCAGggaagdggCtggtg 
-3g4 intton 
ax01 3 
tttttgtgtggtCttcc~GCACCACCAGGACCAGCTGATCATTCCAGCCCACAGC~~ 
intron 4-m38 +l 
Fig. 2. Exon-intron organization and nucleotide sequences of Y-flank- 
ing regions of human PAF receptor gene. The nucleotide sequences 
of three exons and the exon-intron junctions were determined. Exon 
sequences are shown in upper-case letters and intron sequences are in 
lower-case letters. Numbers on the left are relative to the adenosine 
in the first ATG codon. The underlined sequences a~ and gJ indicate 
the nucleotides of introns which correspond to the consensus equence 
of intron-exon junctions. Transcription start sites are marked with 
asterisks and +. Underlinings indicate common binding sequences. 
The repeat structure is indicated by solid-line box (12-bp repeat) and 
dashed-line box (32-bp repeat). 
the heart-type transcript (Transcript 2) contained nei- 
ther TATA nor CCAAT box. In the sequence between 
-672 and -529, we noted a tandem repeat structure 
consisting of a 12-bp box (repeat 1) and a 32-bp box 
kb kb 
:;; 
.6.0 
-5.4 
(repeat 2). Repeat 2 contained consensus equences for 
transcription factor AP-2. Furthermore, Transcript 2 
had Sp-1 and AP-1 binding sites. 
3.5. Expression of both forms of transcripts in different 
tissues 
Since distinct transcription initiation sites were deter- 
mined in exons 1 and 2, two promoters seem to control 
PAF receptor gene expression to yield two forms of 
transcripts. To examine the expression of both tran- 
scripts in tissues and cells, RT-PCR study was designed. 
Primer Cl (5’-CCCGAGCACAAAGATGATGC-3’, 
complementary to nucleotide 87 to 68 of exon 3) was 
chosen to be common to Transcripts 1 and 2, and two 
‘upstream’ primers Ll and Hl were designed to allow 
for specific amplification of either one of the two forms. 
PCR products were analyzed on ethidium bromide- 
stained agarose gels. Since primers Ll, Hl, and Cl lie 
132 
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Fig. 4. Mapping of the transcriptional start site of human PAF receptor gene by primer extension analysis. (A) As depicted in the diagram at the 
bottom of the figure, a 22-mer synthetic oligonucleotide complementary to nucleotides -60 to -39 in the cDNA sequence for exon 1 of human 
PAF receptor was 5’ end-labeled with 32P, annealed to 3 fig poly(A)’ RNA from EoL-1 cells, and extended as described in section 2. (B) Similarly, 
a 20-mer synthetic oligonucleotide complementary to nucleotide - 149 to - 169 in the cDNA sequence for exon 2 was 5’end-labeled with 32P, annealed 
to 3 pg poly(A)’ RNA from heart, and extended. The products were analyzed by electrophoresis on a 6% polyacrylamide gel containing 8 M urea. 
Marker lanes C, T, A, and G indicate sequencing ladders of exon 1 or 2, using the same primer. The arrows indicate the major start sites of 
transcription. 
on different exons separated by introns, PCR fragments 
of expected sizes were derived from mRNAs. Amplifica- 
tion products by PCR from Transcript 1 were found in 
all tissues and the cell line examined (Fig. 5A). How- 
ever, Transcript 2 was not detected in leukocytes, EoL- 1 
cells or brain (Fig. 5B). The different distribution of two 
transcripts uggests that their expression is differentially 
regulated by use of a dual promoter system. In addition, 
two mRNAs may differ in the stability or transcrip- 
tional efficiency. More quantitative analysis of the ex- 
pression level of two transcripts in various tissues and 
their regulation require further investigation. 
Similar cases of alternative 5’-termini and promoters 
found in distinct exons have been reported for the 
A B 
+ 252 bp 
Fig. 5. PCR analysis for expression of two forms of transcripts. Amplification products from EoL-1 cells, leukocytes, brain, heart, lung, spleen, 
kidney using the primer-pairs LllCl (191-bp fragment) and HI/Cl (252-bp fragment) were examined by separation in agarose gels. Primer Cl is 
complementary to the genomic sequences between +68 and +87 to the ATG in the exon 3. Primer Ll is the sequence between -104 and -85 in 
the exon 1. Primer Hl is the sequence between -165 and -145 in the exon 2. Identical PCR reaction mixtures were used for all amplifications except 
for the addition of either one of primer Ll or Hl. 
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mouse glucocorticoid receptor gene [22] and the human 
dystrophin gene [23,24]. As discussed by Schibler and 
Sierra [25] and Kozak [26], transcription of a single gene 
from multiple promoters provides additional flexibility 
in the control of gene expression. Such promoters could 
have different cell type- and/or development-specific a - 
tivities. Elucidation of the existence of two distinct pro- 
moters is thus an important step to decipher expres- 
sional regulation of the PAF receptor gene. 
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